FROM in-Pharmatechnologist.com:
InMed Pharmaceuticals is developing a gel-based cannabinoid drug for eye diseases such as glaucoma, which it says could be cheaper and more accessible than cannabinoid-based products on the market.
READ THE ARTICLE HERE
Read More